INTERVENTIONAL CARDIOLOGY

Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation

Duk-Woo Park¹, Cheol Whan Lee¹, Sung-Cheol Yun², Young-Hak Kim¹, Myeong-Ki Hong¹, Jae-Joong Kim¹, Seong-Wook Park¹, Seung-Jung Park¹

¹ Department of Medicine, Division of Epidemiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
² Department of Medicine, Division of Biostatistics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea

Correspondence to:
Dr S-J Park
Department of Medicine, University of Ulsan College of Medicine, Cardiac Center, Asan Medical Center, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, South Korea; sjpark{at}amc.seoul.kr

Objective: To determine the association of preprocedural C reactive protein (CRP) levels with angiographic restenosis and adverse clinical events after drug-eluting stent (DES) implantation.

Design: A prospective cohort analysis of preprocedural CRP levels as a predictor of serious ischaemic complications or binary restenosis in patients treated with DES.

Setting: Tertiary referral centre.

Patients: 1650 consecutive patients who underwent successful DES implantation. Patients were grouped into tertiles according to preprocedural CRP values for data analysis.

Interventions: Successful DES implantation.

Main outcome measures: The primary end point was a major coronary event, defined as cardiac death or Q-wave myocardial infarction.

Results: Baseline clinical and angiographic characteristics were similar between the tertile groups, except that more patients had multivessel disease and acute coronary syndrome with increasing tertiles of CRP levels. At 1-year follow-up, a primary end point occurred in 4 (0.7%) patients of the lowest tertile, in 3 (0.5%) patients of the middle tertile and in 16 (2.9%) patients of the highest tertile (p = 0.003). In multivariate analysis, the highest tertile of CRP levels was an independent predictor of a major coronary event (HR 4.68, 95% CI 1.91 to 11.44, tertile III vs tertiles I and II, p = 0.001). However, restenosis rates were similar in all three groups (9.1% vs 11.4% vs 11.6%, respectively, p = 0.3).

Conclusions: Preprocedural CRP levels are significantly associated with major coronary events after DES implantation. However, preprocedural CRP levels do not predict subsequent restenosis. Baseline CRP levels may be useful to guide adjunctive management for preventing serious ischaemic events in patients undergoing DES implantation.

Abbreviations: BMS, bare metal stent; CRP, C reactive protein; DES, drug-eluting stent; MI, myocardial infarction; MLD, minimal luminal diameter

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Niccoli, G., Schiavino, D., Belloni, F., Ferrante, G., La Torre, G., Conte, M., Cosentino, N., Montone, R. A., Sabato, V., Burzotta, F., Trani, C., Leone, A. M., Porto, I., Pieroni, M., Patriarca, G., Crea, F. (2009). Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur Heart J 30: 1340-1347 [Abstract] [Full Text]  
• Iijima, R, Byrne, R A, Ndrepepa, G, Braun, S, Mehilli, J, Berger, P B, Schomig, A, Kastrati, A (2009). Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart 95: 107-112 [Abstract] [Full Text]